248. Deputy Bernard J. Durkan asked the Minister for Health if his attention has been drawn to the possible dangers to sufferers of epilepsy arising from the use of generic drugs; if any particular approach has been made to the manufacturers of brand name drugs with a view to a price reduction which would make them more competitive in price with the generic product; and if he will make a statement on the matter. [53355/12]

Summary

248. Deputy Bernard J. Durkan asked the Minister for Health if his attention has been drawn to the possible dangers to sufferers of epilepsy arising from the use of generic drugs; if any particular approach has been made to the manufacturers of brand name drugs with a view to a price reduction which would make them more competitive in price with the generic product; and if he will make a statement on the matter. [53355/12]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Supply

  xml · EN · 28 November 2012

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.